{'fraction_non_alphanumeric': 0.04223433242506812, 'fraction_numerical': 0.005449591280653951, 'mean_word_length': 4.833333333333333, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Rome IV Diagnostic Criteria for Irritable Bowel Syndrome in polycystic ovary syndrome patients

occurrence in PCOS+IBS (4.17%) vs. PCOS-only (4%). QoL appeared to be significantly lower in PCOS+IBS patients vs. PCOS-only. Simple obesity, visceral obesity, and hyperandrogenism did not influence IBS prevalence in PCOS patients. Alarm symptoms were more common in the PCOS group vs. controls. MS was more prevalent in IBS+PCOS vs. PCOS-only subjects. There seem to be no significant differences between IBS occurrence in PCOS vs. healthy women. Obesity, hyperandrogenism, biochemical-hormonal disturbances seem not to affect IBS prevalence in PCOS. IBS screening is advised in PCOS patients due to its potential negative impact on QoL.